| Authors: |
Nyombayire J; Projet San Francisco, Kigali, Rwanda., Anzala O; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi., Gazzard B; Chelsea and Westminster Healthcare NHS Foundation Trust., Karita E; Projet San Francisco, Kigali, Rwanda., Bergin P; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Hayes P; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Kopycinski J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Omosa-Manyonyi G; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi., Jackson A; Chelsea and Westminster Healthcare NHS Foundation Trust., Bizimana J; Projet San Francisco, Kigali, Rwanda., Farah B; Kenya AIDS Vaccine Initiative Institute of Clinical Research, Nairobi., Sayeed E; International AIDS Vaccine Initiative, New York, New York., Parks CL; International AIDS Vaccine Initiative, New York, New York., Inoue M; ID Pharma, Tsukuba., Hironaka T; ID Pharma, Tsukuba., Hara H; ID Pharma, Tsukuba., Shu T; ID Pharma, Tsukuba., Matano T; University of Tokyo.; National Institute of Infectious Diseases, Tokyo, Japan., Dally L; Emmes Corporation, Rockville, Maryland., Barin B; Emmes Corporation, Rockville, Maryland., Park H; International AIDS Vaccine Initiative, New York, New York., Gilmour J; Human Immunology Laboratory, International AIDS Vaccine Initiative, London, United Kingdom., Lombardo A; International AIDS Vaccine Initiative, New York, New York., Excler JL; International AIDS Vaccine Initiative, New York, New York., Fast P; International AIDS Vaccine Initiative, New York, New York., Laufer DS; International AIDS Vaccine Initiative, New York, New York., Cox JH; International AIDS Vaccine Initiative, New York, New York. |
